UBS Group’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.1K | Sell |
27,342
-5,477
| -17% | -$18.5K | ﹤0.01% | 6041 |
|
|
2025
Q1 | $127K | Sell |
32,819
-33,768
| -51% | -$130K | ﹤0.01% | 5606 |
|
|
2024
Q4 | $411K | Buy |
66,587
+51,707
| +347% | +$319K | ﹤0.01% | 4826 |
|
|
2024
Q3 | $80.1K | Buy |
14,880
+1,520
| +11% | +$8.18K | ﹤0.01% | 5317 |
|
|
2024
Q2 | $44.8K | Sell |
13,360
-19,673
| -60% | -$65.9K | ﹤0.01% | 5627 |
|
|
2024
Q1 | $133K | Sell |
33,033
-17,408
| -35% | -$70.2K | ﹤0.01% | 4939 |
|
|
2023
Q4 | $134K | Buy |
50,441
+32,377
| +179% | +$85.8K | ﹤0.01% | 4834 |
|
|
2023
Q3 | $42.6K | Sell |
18,064
-6,098
| -25% | -$14.4K | ﹤0.01% | 5266 |
|
|
2023
Q2 | $152K | Buy |
24,162
+23,956
| +11,629% | +$151K | ﹤0.01% | 4634 |
|
|
2023
Q1 | $1.19K | Sell |
206
-155,821
| -100% | -$899K | ﹤0.01% | 7685 |
|
|
2022
Q4 | $1.6M | Buy |
+156,027
| New | +$1.6M | ﹤0.01% | 2741 |
|
|
2022
Q2 | – | Sell |
-998
| Closed | -$16K | – | 9338 |
|
|
2022
Q1 | $16K | Buy |
998
+963
| +2,751% | +$15.4K | ﹤0.01% | 6687 |
|
|
2021
Q4 | $1K | Sell |
35
-1,099
| -97% | -$31.4K | ﹤0.01% | 8832 |
|
|
2021
Q3 | $17K | Buy |
1,134
+636
| +128% | +$9.53K | ﹤0.01% | 6189 |
|
|
2021
Q2 | $10K | Buy |
498
+198
| +66% | +$3.98K | ﹤0.01% | 6928 |
|
|
2021
Q1 | $9K | Buy |
+300
| New | +$9K | ﹤0.01% | 6968 |
|